Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies

Clinical trial NCT01113476 · COMPLETED

Trial details

NCT number: NCT01113476
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2010-04-27
Primary completion: 2022-08-12
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.